227 related articles for article (PubMed ID: 29197745)
1. Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment.
D'Uva G; Baci D; Albini A; Noonan DM
Cancer Treat Rev; 2018 Feb; 63():1-18. PubMed ID: 29197745
[TBL] [Abstract][Full Text] [Related]
2. The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review.
Li Y; Cui J; Jia J
Curr Cancer Drug Targets; 2021; 21(1):21-54. PubMed ID: 33023449
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 1 family and cancers.
Go RE; Hwang KA; Choi KC
J Steroid Biochem Mol Biol; 2015 Mar; 147():24-30. PubMed ID: 25448748
[TBL] [Abstract][Full Text] [Related]
4. CYP1B1: A Promising Target in Cancer Drug Discovery.
Fabris M; Luiza Silva M; de Santiago-Silva KM; de Lima Ferreira Bispo M; Goes Camargo P
Anticancer Agents Med Chem; 2023; 23(9):981-988. PubMed ID: 36655529
[TBL] [Abstract][Full Text] [Related]
5. Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4' hydroxy tangeretin.
Surichan S; Arroo RR; Tsatsakis AM; Androutsopoulos VP
Toxicol In Vitro; 2018 Aug; 50():274-284. PubMed ID: 29626627
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells.
Wilsher NE; Arroo RR; Matsoukas MT; Tsatsakis AM; Spandidos DA; Androutsopoulos VP
Food Chem Toxicol; 2017 Dec; 110():383-394. PubMed ID: 29097115
[TBL] [Abstract][Full Text] [Related]
7. Discovery of cytochrome P450 1B1 inhibitors as new promising anti-cancer agents.
Chun YJ; Kim S
Med Res Rev; 2003 Nov; 23(6):657-68. PubMed ID: 12939788
[TBL] [Abstract][Full Text] [Related]
8. The Synthesis of Chalcones as Anticancer Prodrugs and their Bioactivation in CYP1 Expressing Breast Cancer Cells.
Ruparelia KC; Zeka K; Ijaz T; Ankrett DN; Wilsher NE; Butler PC; Tan HL; Lodhi S; Bhambra AS; Potter GA; Arroo RRJ; Beresford KJM
Med Chem; 2018; 14(4):322-332. PubMed ID: 29332599
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme.
Sharma R; Gatchie L; Williams IS; Jain SK; Vishwakarma RA; Chaudhuri B; Bharate SB
Bioorg Med Chem Lett; 2017 Dec; 27(24):5400-5403. PubMed ID: 29150398
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.
Cui J; Meng Q; Zhang X; Cui Q; Zhou W; Li S
J Med Chem; 2015 Apr; 58(8):3534-47. PubMed ID: 25799264
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition.
Lo SN; Shen CC; Chang CY; Tsai KC; Huang CC; Wu TS; Ueng YF
Drug Metab Dispos; 2015 Jul; 43(7):1100-7. PubMed ID: 25953522
[TBL] [Abstract][Full Text] [Related]
12. Quinazoline derivatives as selective CYP1B1 inhibitors.
Mohd Siddique MU; McCann GJ; Sonawane VR; Horley N; Gatchie L; Joshi P; Bharate SB; Jayaprakash V; Sinha BN; Chaudhuri B
Eur J Med Chem; 2017 Apr; 130():320-327. PubMed ID: 28259840
[TBL] [Abstract][Full Text] [Related]
13. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
15. Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.
Swanson HI; Njar VC; Yu Z; Castro DJ; Gonzalez FJ; Williams DE; Huang Y; Kong AN; Doloff JC; Ma J; Waxman DJ; Scott EE
Drug Metab Dispos; 2010 Apr; 38(4):539-44. PubMed ID: 20233842
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cancer-related genes - Cyp1a1, Cyp1b1, Cyp19, Nqo1 and Comt - expression in β-naphthoflavone-treated mice by miroestrol.
Chatuphonprasert W; Jarukamjorn K; Putalun W
J Pharm Pharmacol; 2016 Apr; 68(4):475-84. PubMed ID: 26893163
[TBL] [Abstract][Full Text] [Related]
17. Modulation of human cytochrome P450 1B1 expression by 2,4,3',5'-tetramethoxystilbene.
Chun YJ; Lee SK; Kim MY
Drug Metab Dispos; 2005 Dec; 33(12):1771-6. PubMed ID: 16120791
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2-Receptor Antagonists Down-Regulate CYP1A1/2 and CYP1B1 in the Rat Liver.
Harkitis P; Daskalopoulos EP; Malliou F; Lang MA; Marselos M; Fotopoulos A; Albucharali G; Konstandi M
PLoS One; 2015; 10(10):e0128708. PubMed ID: 26466350
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and docking studies of trans-stilbene methylthio derivatives as cytochromes P450 family 1 inhibitors.
Wierzchowski M; Dutkiewicz Z; Gielara-Korzańska A; Korzański A; Teubert A; Teżyk A; Stefański T; Baer-Dubowska W; Mikstacka R
Chem Biol Drug Des; 2017 Dec; 90(6):1226-1236. PubMed ID: 28632937
[TBL] [Abstract][Full Text] [Related]
20. The synthesis of 4,6-diaryl-2-pyridones and their bioactivation in CYP1 expressing breast cancer cells.
Ruparelia KC; Lodhi S; Ankrett DN; Wilsher NE; Arroo RRJ; Potter GA; Beresford KJM
Bioorg Med Chem Lett; 2019 Jun; 29(11):1403-1406. PubMed ID: 30935796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
